Sensorineural Deafness and Seizures in Mice Lacking Vesicular Glutamate Transporter 3  by Seal, Rebecca P. et al.
Neuron
ArticleSensorineural Deafness and Seizures in Mice
Lacking Vesicular Glutamate Transporter 3
Rebecca P. Seal,1 Omar Akil,2 Eunyoung Yi,3 Christopher M. Weber,2 Lisa Grant,3 Jong Yoo,4 Amanda Clause,5
Karl Kandler,5 Jeffrey L. Noebels,4 Elisabeth Glowatzki,3 Lawrence R. Lustig,2 and Robert H. Edwards1,*
1Departments of Physiology and Neurology
2Department of Otolaryngology
School of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
3Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
4Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
5Departments of Otolaryngology and Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
*Correspondence: robert.edwards@ucsf.edu
DOI 10.1016/j.neuron.2007.11.032SUMMARY
The expression of unconventional vesicular gluta-
mate transporter VGLUT3 by neurons known to re-
lease a different classical transmitter has suggested
novel roles for signaling by glutamate, but this distri-
bution has raised questions about whether the pro-
tein actually contributes to glutamate release. We
now report that mice lacking VGLUT3 are profoundly
deaf due to the absence of glutamate release from
hair cells at the first synapse in the auditory pathway.
The early degeneration of some cochlear ganglion
neurons in knockout mice also indicates an impor-
tant developmental role for the glutamate released
by hair cells before the onset of hearing. In addition,
the mice exhibit primary, generalized epilepsy that is
accompanied by remarkably little change in ongoing
motor behavior. The glutamate release conferred by
expression of VGLUT3 thus has an essential role in
both function and development of the auditory path-
way, as well as in the control of cortical excitability.
INTRODUCTION
Synaptic transmission mediated by glutamate requires transport
of the excitatory amino acid into secretory vesicles by a family of
three vesicular glutamate transporters (VGLUTs) (Fremeau et al.,
2004b; Takamori, 2006). Since all cells contain glutamate for its
role in protein biosynthesis and intermediary metabolism,
VGLUT expression thus appears to define neurons that release
glutamate as a neurotransmitter. Consistent with this, heterolo-
gous expression of VGLUT1 and -2 in inhibitory neurons suffices
to confer regulated glutamate release (Takamori et al., 2000,
2001). In addition, analysis of VGLUT expression patterns has re-
vealed a number of neuronal populations not previously thought
to release glutamate (Boulland et al., 2004; Gras et al., 2005).
The three VGLUT isoforms exhibit a mutually exclusive distri-
bution in the adult brain, suggesting a distinct role for each pro-
tein. VGLUT1 and -2 are the predominant isoforms and together
include essentially all of the neurons previously shown to releaseglutamate as a transmitter (Fremeau et al., 2001; Herzog et al.,
2001; Kaneko et al., 2002; Varoqui et al., 2002). In contrast,
VGLUT3 is expressed by neuronal populations that are usually
associated with the release of a transmitter other than glutamate,
such as serotonergic neurons in the dorsal and medial raphe nu-
clei and cholinergic interneurons in the striatum (Fremeau et al.,
2002; Gras et al., 2002; Schafer et al., 2002). In the hippocampus
and cortex, VGLUT3 is expressed by GABAergic interneurons
that form perisomatic, symmetric synapses usually associated
with inhibitory transmission (Fremeau et al., 2002). In addition,
VGLUT3 has been detected outside the nervous system in liver,
kidney, and muscle (Boulland et al., 2004; Fremeau et al., 2002;
Gras et al., 2002; Schafer et al., 2002).
VGLUT3 also differsmarkedly from the other two isoforms in its
membrane trafficking (Voglmaier et al., 2006). VGLUT1and -2 rely
on distinct interactions with the endocytic machinery for recy-
cling but remain almost exclusively axonal. In contrast, VGLUT3
can target to the cell body and dendrites, as well as the axon of
certain neurons (Fremeau et al., 2002; Gras et al., 2002), and
has been implicated in the retrograde synaptic release of gluta-
mate (Harkany et al., 2004).
The unusual distribution of VGLUT3 has suggested novel roles
for signaling by glutamate. Although the three isoforms exhibit
similar transport activity using in vitro assays, heterologous ex-
pression of VGLUT3 in neurons has not conferred detectable
postsynaptic responses to glutamate (Takamori et al., 2000,
2001), raising questions about whether the protein actually con-
tributes to glutamate release. We therefore produced mice lack-
ing VGLUT3 and now report that the transporter indeedmediates
the regulated exocytosis of glutamate and as such has a critical
role in both the auditory pathway and the control of cortical
excitability.
RESULTS
To determine the physiological role of VGLUT3, we produced
mice that lack the transporter by homologous recombination in
mouse embryonic stem cells, deleting the first transmembrane
domain and lumenal loop of the protein (Figure 1A). Disruption
of the gene was confirmed by Southern analysis and PCR, and
the loss of VGLUT3 protein was confirmed by immunostainingNeuron 57, 263–275, January 24, 2008 ª2008 Elsevier Inc. 263
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1E). VGLUT3 knockout (KO) mice are born in the expected Men-
delian ratios and do not exhibit any obvious anatomic or motor
abnormalities. Brain architecture as well as the number andmor-
phology of neuronal populations known to express VGLUT3
show no obvious difference from wild-type (WT) littermates (Fig-
ures 1E and 1F and data not shown).
Sensorineural Deafness in VGLUT3 Knockout Mice
VGLUT3 is expressed during development by a population of
GABAergic neurons in the auditory brainstem pathway where it
may contribute to the tonotopic refinement required for sound
localization (Gillespie et al., 2005). VGLUT3 KOmicemight there-
fore be expected to exhibit a subtle deficit in auditory acuity.
However, the mice do not startle in response to even a loud
clap. To quantify their response to sound, we used acoustic star-
tle chambers. As shown in Figure 2A, VGLUT3 KO animals show
no startle to sound as loud as 125 dB, whereas WT littermates
exhibit a robust startle at much lower intensities. On the other
hand, VGLUT3 KOmice show a normal righting reflex and perfor-
mance on the rotorod (data not shown), suggesting normal
motor and vestibular function.
Since the absence of startle to sound could reflect an impair-
ment of pathways not related specifically to hearing, we as-
sessed auditory function more directly. The auditory brainstem
response (ABR) measures evoked potentials time-locked to the
onset of sound at synapses along the auditory pathway, starting
with the inner hair cell (IHC)-auditory nerve synapse. VGLUT3 KO
mice and WT littermates were subjected on postnatal day 21
(P21) to broadband clicks at intensities ranging from 23.1 to
91.5 dB sound pressure level (SPL). In contrast to WT and
VGLUT3 heterozygous mice, which begin to show an ABR
(ABR threshold) at 35 dB SPL, VGLUT3 KO mice show no re-
sponse over the range of intensities tested, indicating profound
deafness (Figures 2B and 2C). We also tested the ABR at three
different frequencies: 8, 16, and 32 kHz. Again, VGLUT3 KO
mice show no response at up to 88.1 dB SPL (the highest inten-
sity tested) for all three frequencies (Figure 2B).
The absence of evoked potentials under all conditions sug-
gests that deafness in the VGLUT3 KO mice results from a pe-
ripheral defect in the cochlea or afferent neuronal pathway. We
thus assessed mechanoelectrical transduction and the electro-
motility of outer hair cells (OHCs) by analyzing otoacoustic emis-
sion spectra (Figure 2D). VGLUT3 KO and heterozygous mice
show no difference fromWT littermates in otoacoustic emissions
measured over a range of frequencies and at multiple intensities
(Figure 2D and data not shown). This evidence for intact cochlear
sound amplification, together with the lack of ABR evoked
Figure 1. Targeted Disruption of the
VGLUT3 Locus
(A) Restriction maps of the WT VGLUT3 mouse
gene locus, the targeting construct, and the prop-
erly recombined allele. In the recombined allele,
most of exon 2 is replaced by EGFP (green box)
and the positive selectable marker for resistance
to neomycin (neo). The neo gene, flanked by
loxP sites, was deleted by mating mice heterozy-
gous for VGLUT3 to b-actin-cre mice that express
cre recombinase in the germline. Exon 2 encodes
the first transmembrane domain and part of the
first lumenal loop of VGLUT3, including glycosyla-
tion sites. The 50 probe (blue box) used to identify
properly targeted ES cell clones resides upstream
of the left arm.
(B) Southern blot of BamH1-cut genomic DNA
from three neomycin-resistant ES cell clones.
The wild-type allele results in an 22 kb band,
whereas the targeted allele results in an 8 kb
fragment.
(C) PCR amplification of genomic tail DNA from
wild-type (+/+), heterozygous (+/), and homozy-
gous (/) VGLUT3 knockout (KO) mice. A 720
bp band is amplified from the wild-type allele,
and a 330 bp band from the recombined allele.
(D) Western blot of crude brain synaptic vesicles
prepared from wild-type (+/+) and VGLUT3 KO
(/) littermates probed with antibodies to
VGLUT3 and synaptophysin (syp).
(E) Striatal, hippocampal, and cortical slices from
wild-type (WT) and VGLUT3 KO mice were immu-
nostained for VGLUT3 (red) and VAChT, VGLUT1,
or VGLUT2 (all green).
(F) Hippocampal region CA1 (top) and parietal cor-
tex (bottom) of VGLUT3 KO mice show no differ-
ence from WT in overall morphology assessed by
Nissl stain (green).264 Neuron 57, 263–275, January 24, 2008 ª2008 Elsevier Inc.
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VGLUT3 KO Mice
(A) Acoustic startle response of VGLUT3 KO mice
(open circles, n = 7) and WT littermates (filled
circles, n = 7) at sound intensities from 80 to
125 dB sound pressure level (SPL). KO mice
show no response at any intensity.
(B) Auditory brainstem response (ABR) thresholds
to click stimuli (up to 91.5 dB SPL) or pure tones (8,
16, and 32 kHz, at up to 88.1 dB SPL) for P21 WT
(filled circles, n = 5), VGLUT3 heterozygotes (gray
circles, n = 5), and VGLUT3 KOmice (open circles,
n = 5). VGLUT3 KO mice show no response. Wild-
type mice show an impairment at high frequency,
consistent with impaired high-frequency hearing
in the C57Bl/6 mice to which the VGLUT3 KO
were backcrossed.
(C) Representative ABR (P21) and compound ac-
tion potentials (CAP) (P14–17) for WT and VGLUT3
KO mice. A small stimulus artifact that precedes
the onset of the CAP in WT mice is all that remains
in the KO.
(D) Distortion product otoacoustic emissions
spectra (DPOAE) measured at 65 dB SPL show
no difference between WT (filled circles, n = 5),
VGLUT3 heterozygotes (gray circles, n = 5), and
VGLUT3 KO mice (open circles, n = 5). Nf is the
noise floor measurement.
(E) ABR thresholds to click stimuli (up to 91.5 dB
SPL) or pure tones (8, 16, and 32 kHz, at up to
88.1 dB SPL) for P21 WT (filled circles, n = 4)
show no difference from VGLUT1 heterozygotes
(gray circles, n = 5) and VGLUT1 KO mice (open
circles, n = 4).
Error bars indicate the standard error of the mean.potentials, indicates that a defect at the IHC-afferent synapse
may underlie the deafness in VGLUT3 KO animals. To identify
more precisely the location of the defect in sound-evoked poten-
tials, wemeasured the auditory nerve compound action potential
(CAP) elicited by sound (91.5 dB SPL), recording at the round
window (Figure 2C). Under these conditions, we observed
a large, complex waveform in P14–17 WTmice and no response
in the KO (n = 4). The absence of even the earliest response to
stimulation strongly suggests a defect in signaling between
IHC and auditory nerve.
To determine whether an anatomical defect accounts for the
deafness of VGLUT3 KO mice, we examined the morphology
of the cochlea and spiral ganglion. By light microscopy, both in-
ner and outer hair cells appear normal in P21 VGLUT3 KO mice
(Figure 3A). By electron microscopy, P21 KO mice show abnor-
mally thin, elongated ribbons in 26 out of 31 IHC synapses exam-
ined from three different KO animals. The morphology of synap-
ses appeared normal in 5/31 IHC synapses from KO and 25/25
synapses from three WT mice (Figure 3B). However, the abnor-
mality in synaptic ribbons seems unlikely to account for the deaf-
ness observed because bassoon knockout mice with almost no
synaptically anchored ribbons exhibit a substantially milder
hearing deficit (Khimich et al., 2005). We also counted the num-
ber of synaptic vesicles per section. WT mice show 12.7 ± 0.5
vesicles associated with ribbons (n = 18), and VGLUT3 KO
mice show 12.8 ± 2.0 (n = 17). WT animals show 2.3 ± 0.6 vesi-cles morphologically docked at the plasma membrane, and
VGLUT3 KO show 1.6 ± 0.6 (p > 0.07). The VGLUT3 KO thus
does not differ significantly from WT in the number of synaptic
vesicles tethered to ribbons or docked at the plasmamembrane.
In the spiral ganglion, VGLUT3 KO mice exhibit a progressive
loss of neurons at all levels of the cochlea (apex, mid-turn, base)
that becomes readily apparent by P10 (Figure 3C, Table 1, and
data not shown). Consistent with this, the cochlear nucleus,
which contains projections from the spiral ganglion, shows a re-
duced volume (Figure 3D). However, this moderate neuronal loss
also seems unlikely to account for the complete absence of
CAPs observed in P14 KO mice (Figure 2C).
Inner Hair Cells Express VGLUT3
Immunofluorescence for all three VGLUT isoforms at P21 shows
that IHCs label only for VGLUT3 (Figure 4A). Its distribution re-
sembles that observed for other elements of the IHC releasema-
chinery, including the SNARE proteins VAMP1, SNAP-25, and
syntaxin 1 that mediate vesicle fusion with the plasma mem-
brane, and the putative calcium sensor otoferlin (Figure 4A)
(Roux et al., 2006; Safieddine and Wenthold, 1999). We did not
detect expression of VGLUT3 elsewhere in the organ of Corti.
Sparse, punctate VGLUT1 and light VGLUT2 immunoreactivity
surround inner and outer hair cells but do not colocalize with
hair cell markers or the efferent synaptic vesicle protein synapto-
physin (data not shown). To confirm the specificity of labeling, weNeuron 57, 263–275, January 24, 2008 ª2008 Elsevier Inc. 265
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no immunoreactivity for VGLUT3 (Figure 4A). In addition, the
IHCs of VGLUT3 KO mice show no upregulation of VGLUT1 or
-2 (data not shown).
The VGLUTs undergo developmental regulation in other parts
of the nervous system (Boulland et al., 2004; Fremeau et al.,
2004a; Gras et al., 2005; Miyazaki et al., 2003), raising the possi-
Figure 3. The Loss of VGLUT3 Affects Inner
Hair Cell Ribbons and Spiral Ganglion Cell
Survival
(A) Surface preparation of sensory hair cells from
the apex, mid-turn, and base of P21 VGLUT3 KO
mice shows no difference from WT by staining
with rhodamine-phalloidin.
(B) Electron microscopy of inner hair cells (IHC)
from P21 VGLUT3 KO (/) mice shows abnor-
mally thin, elongated ribbons. IHC ribbon synap-
ses from WT littermates (+/+) are shown for refer-
ence. 40,0003 magnification.
(C) Sections from the mid-turn of WT and VGLUT3
KO cochlea at P4, P10, and P21 were stained with
osmium tetroxide and toluidine blue. Spiral ganglia
(outlined in red) from KO animals show fewer cells
than WT at P10 and P21. The nerve fiber bundle
(arrows) is also thinned in VGLUT3 KO mice.
(D) Volume of the posteroventral cochlear nucleus
(PVCN) and AVCN but not dorsal cochlear nucleus
(DCN) is significantly reduced in VGLUT3 KOmice.
(n = 4, p < 0.01, Student’s t test.)
Error bars indicate standard error of the mean.
Table 1. Density of Spiral Ganglion Neurons in WT and VGLUT3
KO Mice
P10 P21
WT KO WT KO
Apex 1056 ± 76 812 ± 68* 800 ± 63 517 ± 20***
Mid-turn 1042 ± 88 804 ± 42* 799 ± 25 486 ± 21***
Base 867 ± 16 536 ± 9** 709 ± 64 374 ± 10***
Spiral ganglion densities (cells/mm2) at the apex, mid-turn, and base
were calculated for VGLUT3 KO and WT mice at P10 and P21. Values
indicate mean ± standard deviation, and significance was determined
by Student’s t test, with p < 0.05 denoted by *, p < 0.01 by **, and p <
0.005 by ***.
bility that their transient expression at
a critical time in development might exert
a long-term effect on hearing.We thus ex-
amined the time course of VGLUTexpres-
sion in the cochlea. At E15, IHCs do not
express any of the VGLUTs. However,
by E19 and at all subsequent ages tested,
the IHCs express VGLUT3 (Figure 4B).
Around the time of birth, OHCs labeled
weakly for VGLUT3 (Figure 4B), but
VGLUT1 and -2were not detected in inner
or outer hair cells at any age (Figure 4A
and data not shown). The sole expression of VGLUT3 by IHCs
throughout development and maturity suggests that the degen-
eration observed in KO mice results directly from an impairment
in glutamate release.
To assess further VGLUT expression by IHCs, we have used
RT-PCR. In IHCs (obtained from rat due to the more precise dis-
section), we detect only mRNA for VGLUT3 and the nicotinic re-
ceptor subunit (nAChR) a9 (Figure 4C), a gene expressed in the
cochlea exclusively by hair cells. We do not detect transcripts for
VGLUT1 or -2. In contrast, the cochlea as a whole expresses all
three VGLUT isoforms as well as the a9 nAChR subunit (Fig-
ure 4C). No VGLUT or a9 nAChR transcripts were detectable
by RT-PCR from the dissection medium (data not shown).
Thus, IHCs express only the VGLUT3 isoform.
Since previous work has suggested the expression of VGLUT1
by IHCs (Furness and Lawton, 2003), we also examined hearing
in the VGLUT1 KO mice (Fremeau et al., 2004a). VGLUT1 KO
mice exhibit a robust startle to loud clap, and ABR thresholds
to click and pure tone stimuli do not differ from WT littermates
(Figure 2E). Otoacoustic emission spectra of VGLUT1 KO mice
are also normal (data not shown).266 Neuron 57, 263–275, January 24, 2008 ª2008 Elsevier Inc.
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IHC Conductances Similar to Wild-Type
Morphological abnormalities in the cochlea of VGLUT3 KO mice
raise the possibility that the defect in synaptic transmission re-
sults secondarily from changes in the properties of IHCs or gan-
glion cells rather than a primary defect in transmitter release. We
have therefore examined several key conductances expressed
by IHCs and tested the developmental regulation for some of
them. In hair cells, voltage-gated L-type calcium channels medi-
ate thecalcium influx required to trigger neurotransmitter release.
Recording at the end of the first postnatal week when these cur-
rents reach a transient maximum (Johnson et al., 2005; Moser
and Beutner, 2000), VGLUT3 KO and wild-type mice both exhibit
Figure 4. VGLUT Expression in the Organ of
Corti
(A) Immunofluorescence for VGLUT3 (red) and ei-
ther VGLUT1 (green) or VGLUT2 (green) in cochlea
of P21WTmice shows expression of only VGLUT3
by IHCs. VGLUT3 immunoreactivity (red) localizes
to the IHC in a pattern resembling that of the syn-
aptic vesicle protein otoferlin (green). P21 VGLUT3
KO mice show no immunoreactivity for VGLUT3
(red), while otoferlin expression appears normal
(green). Nuclei are stained with DAPI (blue).
(B) VGLUT3 (red) becomes detectable by immuno-
fluorescence in the cochlea of WT mice by E19.
OHC, outer hair cell; TC, Tunnel of Corti; DC, Dei-
ters cells.
(C) RT-PCR of P13–14 rat IHCs shows expression
of only the VGLUT3 isoform and the nAChR sub-
unit a9, a gene expressed exclusively by hair cells
within the cochlea. The cochlea as a whole ex-
presses all three VGLUT isoforms and the nAChR
a9. No products were detected when RT-PCR
was performed in the absence of reverse tran-
scriptase (RT).
a bell-shaped current-voltage relation-
ship with activation at 64 mV and
peak current at 14 mV (Figures 5A
and 5B). Current amplitudes were not
significantly different between VGLUT3
KO and WT mice over the whole voltage
range (p = 0.7). The rates of activation by
depolarization to 14 mV were also simi-
lar, with time constants of 0.32 ± 0.04 ms
for VGLUT3 KO mice and 0.31 ± 0.03 ms
for WT (p = 0.2). All these features of IHC
calciumchannels are very similar to previ-
ous reports (Brandt et al., 2007; Johnson
et al., 2005; Moser and Beutner, 2000;
Platzer et al., 2000; Sendin et al., 2007).
IHCs fire calcium action potentials be-
fore the onset of hearing (Kros et al.,
1998; Marcotti et al., 2003), and calcium
action potentials were observed sponta-
neously in 7 out of 10 VGLUT3 KO mice
at P7–8 and in 7 out of 9WT animals. Cur-
rent injection induced calcium action
potentials in 5 of 5 KO and 6 of 6 WT (Figure 5C). After the onset
of hearing, however, current injection did not induce calcium ac-
tion potentials in the IHCs of either KO (3 of 3) or WT (8 of 8) mice
(Figure 5D). This loss of excitability is thought to result in part from
the appearance of BK potassium channels, which short-circuit
the generation of calcium action potentials (Kros et al., 1998).
IHCs express multiple developmentally regulated potassium
conductances (Kros et al., 1998; Marcotti et al., 2003; Pyott
et al., 2004). Before hearing, IHCs exhibit slowly activating de-
layed rectifier potassium currents. After hearing onset, a rapidly
activating large conductance calcium-dependent BK current
also appears. Very similar to WT animals, the IHCs of VGLUT3
KO mice show an 20-fold slower activation time constant atNeuron 57, 263–275, January 24, 2008 ª2008 Elsevier Inc. 267
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Hair Cell Conductances Similar to WT
(A) IHC calcium currents recorded from aP7 VGLUT3KOmouse in response to
100 ms depolarizations from 84 mV to +16 mV in 10 mV increments.
(B) Similar current-voltage relationships for calcium currents from P7–8
VGLUT3 KO (n = 9) and WT IHCs (n = 9). Current amplitudes were measured
after full activation, and the values presented are mean ± SE.
(C) Calcium action potentials produced by current injection into a P8 VGLUT3
KO IHC. 100 ms current steps were applied from 40 pA in 10 pA increments.
In this cell, calcium action potentials were generated with +20 pA current injec-
tion. Inset shows spontaneous calcium action potentials recorded from
a VGLUT3 KO IHC in the absence of current injection. Scale: 20 mV and
200 ms.
(D) Using the same protocol, a P16 VGLUT3 KO IHC shows no calcium action
potentials.
(E and F) Potassium currents recorded from P8 (E) and P16 (F) VGLUT3 KO
IHCs in response to 100 ms voltage steps from 104 mV to +26 mV in
10 mV increments from a holding potential of 84 mV (nominal voltages). Ac-
tual voltages reached after correcting for series resistance error are shown
next to selected traces.
(G) Depolarization with 40 mM extracellular potassium activates synaptic cur-
rents from cholinergic efferents in a VGLUT3 KO IHC at P7. Inset shows single
synaptic currents on an expanded timescale (30 pA, 250 ms).268 Neuron 57, 263–275, January 24, 2008 ª2008 Elsevier Inc.P8, before hearing, than at P15–16, after hearing onset (p < 0.01)
(Figures 5E and 5F and Table 2). In addition, the amplitude of out-
ward currents increases 2- to 3-fold from P8 to P15–16 in both
KO and WT mice (p < 0.01) (Figures 5E and 5F and Table 2). At
both ages, there was no difference between the activation time
constant of KO and WT (p > 0.5). However, current amplitudes
are slightly larger for VGLUT3 KO mice (p < 0.01) (see Figure S1
available online). Nonetheless, potassium conductances un-
dergo very similar developmental regulation in both VGLUT3
KO and WT animals.
Before the onset of hearing at P12–14, IHCs receive choliner-
gic inputs that disappear in the third postnatal week (Katz et al.,
2004; Simmons et al., 1996; Simmons, 2002). At P7–8, depolar-
ization of efferents with 40 mM K+ produced synaptic currents
in all the IHCs tested from both VGLUT3 KO (8 of 8) and WT (7
of 7) mice (Figure 5G). In contrast, at P15–16, only a small pro-
portion of IHCs responded (1 of 9 KO and 1 of 8 WT mice)
(Figure 5H). The loss of VGLUT3 thus does not appear to influ-
ence the developmental change in innervation by IHC efferents.
Loss of VGLUT3 Eliminates Synaptic
Glutamate Release from IHCs
To assess directly neurotransmission at the first synapse in the
auditory pathway of VGLUT3 KO mice, we performed whole-
cell recordings from auditory nerve fiber terminals at the site
where they contact the IHC (Glowatzki andFuchs, 2002). The cur-
rent-voltage relationship of afferents from VGLUT3 KO mice
showed features typical of recordings fromWT terminals (Figures
6A and 6B), with a fast sodiumcurrent, low voltage activating and
high voltage activating potassiumconductances, andoccasional
Ih current (E.Y. and E.G., unpublished data). Depolarizing with
20–40 mM K+ to induce synaptic activity, all recordings from
WT mice (n = 10) showed synaptic currents reversibly blocked
by the AMPA receptor antagonist NBQX (10 mM) (Figure 6C).
Spontaneous synaptic currents were also observed at low fre-
quency (<1 Hz) in WT recordings (7 of 10). However, no synaptic
responsewas detected in KOmice (n = 11), evenwith depolariza-
tion by elevated K+ (Figure 6D). To determine whether the ab-
sence of synaptic responsemight be due to the loss of glutamate
receptors, we applied 10–100 mM kainic acid (KA) along with
100 mM cyclothiazide to prevent receptor desensitization. At
a holding potential of 94 mV, kainate induced inward currents
in both WT (5 of 5) and VGLUT3 KO (4 of 4) animals (Figures 6E
and 6F). The kainate-induced currents were blocked by NBQX,
indicating their dependence on AMPA receptors. The afferents
of VGLUT3 KO mice thus exhibit a normal response to direct
receptor stimulation, indicating that the defect in neurotransmis-
sion must be presynaptic, due to a loss of glutamate release.
Nonconvulsive Seizures in VGLUT3 KO Mice
The importance of VGLUT3 for glutamate release by IHCs sug-
gests that the transporter may also contribute to signaling at syn-
apses usually associated with a different transmitter. Indeed,
(H) No synaptic currents are detected in a VGLUT3 KO IHC at P16. The slow
rise in inward current in both (G) and (H) results from the change in K+ equilib-
rium potential produced by addition of 40 mM K+.
Error bars indicate standard error of the mean.
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hippocampus and cortex, suggesting that these neurons release
glutamate as well as GABA (Hioki et al., 2004; Somogyi et al.,
2004). Since signaling by interneurons is known to influence net-
work activity, we monitored 3- to 7-month-old KO animals for ex-
tended periods by combined electroencephalography (EEG) and
digital video. The background cortical activity in all VGLUT3 KO
mice shows frequent (5–10/min) generalized synchronous dis-
charges that were never observed in WT littermates (Figure 7A).
The high-amplitude discharges are of two distinct types, a broad
surface-negative spike and sharp wave complex lasting 200–300
ms and occasional inverted positive sharp spikes, neither of which
was accompanied by myoclonic behavior. This baseline activity
demonstrates a neocortical hyperexcitability usually associated
with convulsive seizures in mousemodels and in humans. Indeed,
EEG recording shows that the VGLUT3 KO animals have intermit-
tent, spontaneous cortical seizures lasting up to 2 min. However,
the mice exhibit remarkably little behavioral accompaniment
throughout the entire electrographic seizure and remain either im-
mobile with no associatedmyoclonic activity or display normal ex-
ploratory behavior (Movies S1 and S2). At seizure onset, the EEG
shows generalized or occasionally unilateral onset of fast spike
and slow wave activity, followed by continuous spike discharges
decelerating to a slow (1–3/s) spike-wave rhythm (Figure 7B).
The episodes conclude with a pattern of alternating accelerated
spikes and spike-wave activity and terminate abruptly by returning
to pre-ictal patterns, with no EEG flattening (Figure 7B andMovies
S1 and S2). These nonconvulsive electrographic seizures occur
once per day on average, and no generalized tonic-clonic motor
activity was observed despite prolongedmonitoring. Interestingly,
mice heterozygous for the VGLUT3 null allele also show interictal
epileptiform abnormalities, but no detectable electrographic
seizures (Figure 7A).
DISCUSSION
The results show that VGLUT3serves asan importantmediator of
glutamate signaling, with essential roles in the auditory system
andcortex. VGLUT3KOmice are entirely deaf, and the loss of au-
ditory brainstem responses indicates a defect early in the audi-
tory pathway, within the cochlea. Intact otoacoustic emissions
exclude a problem with mechanoelectrical transduction or outer
hair cell motility. Rather, the analysis of compound action poten-
tials recorded from the auditory nerve suggests impairment of
neurotransmission at the IHC-afferent synapse. However, the
Table 2. Properties of Inner Hair Cell PotassiumConductances at
P8 and P15–16 for WT and VGLUT3 KO Mice
WT KO
Age tact (ms) amplitude (nA) n tact (ms) amplitude (nA) n
P8 9.6 ± 1.0 3.9 ± 0.3 6 7.4 ± 0.8 5.7 ± 0.6 6
P15–16 0.47 ± 0.1 6.9 ± 0.6 6 0.37 ± 0.1 15.9 ± 1.5 8
Current amplitudes elicited by depolarization to +4 mV, measured at the
end of 100 ms voltage steps. Values are presented as mean ± SE. For
both VGLUT3 KO and WT mice, current amplitudes change significantly
with age (p < 0.01). For P15/16 IHCs, potassium current amplitudes in
VGLUT3 KO mice were significantly larger than in WT (p < 0.01).IHCs of VGLUT3 KO mice exhibit physiological properties very
similar to WT animals. In particular, the IHCs of VGLUT3 KO
mice show normal calcium currents, and at hearing onset, the
normal downregulation of calcium action potentials together
with the appearance of BK potassium conductances, a process
that appears to depend on thyroid hormone (Brandt et al.,
2007; Rusch et al., 2001; Sendin et al., 2007). Afferent nerve
terminals of KO mice also exhibit sodium and potassium
conductances very similar to WT. However, KO afferents lack
synaptically evoked glutamate receptor currents despite normal
responses to exogenous kainate, indicating a specific, presynap-
tic defect in glutamate release. Glutamate has been proposed as
the primary transmitter at the IHC-afferent nerve synapse
(Bobbin, 1979; Comis and Leng, 1979; Ottersen et al., 1998).
Since the only VGLUT isoform expressed by IHCs is VGLUT3,
Figure 6. Absence of Synaptic Activity in the Afferent Terminals of
VGLUT3 KO Mice
(A and B) I-V relationships recorded from IHC afferent terminals in response to
200 ms voltage steps from 104 to +36 mV in 10 mV increments (holding po-
tential 84 mV) show no difference between WT (A) and VGLUT3 KO mice (B).
Inset in (B) shows Na+ currents on an expanded timescale for voltage steps
from 84 to 4 mV (0.5 nA, 1 ms).
(C and D) Afferent terminal responses to depolarization with 40 mM potassium
(holding potential 94 mV) show AMPA receptor-mediated synaptic currents
completely blocked by 10 mMNBQX in WT animals (C). Inset shows individual
synaptic currents on an expanded timescale (50 pA, 2 ms). (D) No synaptic ac-
tivity was detected in the afferent terminals of VGLUT3 KO mice. The slow rise
in inward current in (C) and (D) reflects the change in K+ equilibrium potential
due to addition of 40 mM K+.
(E and F) 100 mM kainate (KA) (with 100 mM CTZ to prevent AMPA receptor
desensitization) evokes inward currents in both WT (E) and VGLUT3 KO (F)
afferent terminals (holding potential 94 mV). Kainate-evoked currents were
completely blocked by 10 mM NBQX.Neuron 57, 263–275, January 24, 2008 ª2008 Elsevier Inc. 269
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(A) Chronic EEG recording shows two distinct types of interictal discharge in VGLUT3 KOmice (/), one a long-lasting spike-wave complex and the other a pos-
itive-going sharp spike discharge. Mice heterozygous for VGLUT3 (+/) also show sharp interictal spike discharges, but no discharges or baseline EEG abnor-
malities were recorded from wild-type (+/+) littermates.
(B) VGLUT3 KO mice show prolonged generalized spike-wave seizure discharges with no apparent effects on motor behavior (Movies S1 and S2). All leads are
recorded using a digital average reference source. Calibration bars: (A) 1.25 s, 500 mV, (B) 1 s, 500 mV. Electrode montage: LF, left frontal; RF, right frontal; T,
temporal; P, parietal; O, occipital.the absence of glutamate release inKOmicemust reflect a loss of
vesicle filling. IHCs have been reported to express VGLUT1 (Fur-
ness and Lawton, 2003), but we could not detect specific expres-
sion of either VGLUT1mRNAor protein by IHCs, and the VGLUT1
KO shows no measurable hearing impairment. The loss of
VGLUT1 or indeed other vesicular neurotransmitter transporters
does not obviously impair synaptic vesicle exo- or endocytosis
(Croft et al., 2005; Wojcik et al., 2004), making it unlikely that
the loss of VGLUT3 would affect these other aspects of the syn-
aptic vesicle cycle.
VGLUT3 belongs to a small number of proteins involved in
neurotransmitter release that have a relatively selective effect
on synaptic signaling by IHCs. Otoferlin, a protein associated
with hereditary deafness in humans (Yasunaga et al., 1999), has
recently been suggested to act as the principal calcium sensor
for regulated exocytosis in mammalian IHCs (Roux et al., 2006).
Deletion of the otoferlin gene inmice results in profounddeafness
due to the loss of synchronous evoked glutamate release at the
IHC-afferent synapse. Similar to the VGLUT3 KO, the IHCs of
otoferlin KO mice show relatively normal ionic conductances.
However, both otoferlin and VGLUT3 KOmice show an increase
in IHC K+ currents at maturity, suggesting feedback of the gluta-
mate signal onto IHCs. In contrast, mice lacking the calcium
channels required for transmitter release do not exhibit the usual270 Neuron 57, 263–275, January 24, 2008 ª2008 Elsevier Inc.appearance of BK potassium currents and loss of efferents seen
in both VGLUT3 KO, otoferlin KO, and WT animals (Brandt et al.,
2003; Nemzou et al., 2006), indicating that these changes do not
rely on synaptic transmission but rather on the specific activity of
calcium channels.
The loss of VGLUT3 produces morphological changes in the
cochlea similar to those previously observed in otoferlin KO an-
imals (Roux et al., 2006). VGLUT3 KO mice show a progressive
reduction in the number of ganglion cells during postnatal devel-
opment, as well as their projections to the brainstem. Indeed,
stimulation (presumably mediated by glutamate) has been
shown to provide trophic support for spiral ganglion cells (He-
garty et al., 1997). The IHCs of both otoferlin and VGLUT3 KO
mice also show abnormal ribbons, although the ribbons in oto-
ferlin KO have defects in anchoring to the synaptic membrane,
and those in VGLUT3 KO exhibit an abnormally elongated mor-
phology. However, the number of synaptic vesicles, their associ-
ation with ribbons, and their morphological docking at the
plasma membrane appear unaffected by the loss of VGLUT3.
TheappearanceofVGLUT3beforebirthprovidesamechanism
for neurotransmission before the onset of hearing, as previously
shown (Eybalin et al., 2004; Glowatzki and Fuchs, 2002; Knipper
et al., 1997). Since spontaneous retinal activity influences devel-
opment of the visual system (Eglen et al., 2003; Firth et al., 2005;
Neuron
VGLUT3 in Hearing and Cortical ExcitabilityShatz, 1996), the early expression of VGLUT3 by IHCsmay there-
fore also contribute to development of the auditory system. In-
deed, the transient expression of VGLUT3 at the synapse made
by medial nucleus of the trapezoid body neurons onto lateral
superior olivary neurons (MNTB-LSO synapse) has suggested
an early role for activity in tonotopic refinement and synaptic
strengthening downstream in the pathway (Gillespie et al.,
2005). Consistent with previous work, the degenerative changes
observed at P10 in VGLUT3 KO mice demonstrate that early
activity has a specific role in development of the auditory system.
Similar to IHCs, retinal photoreceptors and bipolar cells form
ribbon synapses, but express VGLUT1 (Johnson et al., 2003;
Sherry et al., 2003). How might the properties of the unconven-
tional isoform VGLUT3 help to fulfill the specialized function of
the IHC synapse in hearing? Although the isoforms differ little in
their intrinsic transport activity, they diverge substantially in traf-
ficking (Voglmaier et al., 2006). The dendritic targeting of VGLUT3
in multiple neuronal populations (Fremeau et al., 2002; Harkany
et al., 2004) may indeed correspond to its basolateral targeting
in epithelial cells such as IHCs. In addition, IHCs appear to derive
their synaptic vesicles fromat least two sources: one a local recy-
cling pool at the basolateral surface that involves cisternal inter-
mediates (Lenzi et al., 2002), and another pool particularly impor-
tant for sustained, high-frequency synaptic signaling that may
originate on the apical surface (Griesinger et al., 2002, 2005).
The neuronal localization of VGLUT3 in dendrites aswell as axons
is indeed consistent with its trafficking to more than one pool of
secretory vesicles.
The incessant interictal activity and less frequent generalized
seizures observed in VGLUT3 KO mice indicate a major distur-
bance of cortical excitability. A distinguishing feature of these
seizures is the lack of overt changes in ongoing motor behavior.
Absence epilepsy in human patients and animal models involves
brief (1–10 s), highly stereotyped thalamocortical discharges, but
these episodes are always accompanied by behavioral arrest
and often terminate with myoclonus (Noebels and Sidman,
1979). In contrast, VGLUT3 KO mice provide the first genetically
definedmousemodel of pure primary generalized nonconvulsive
epilepsy demonstrating essentially complete electrographic dis-
sociation, with no prominent effects on behavior. The loss of
VGLUT3 appears sufficient to synchronize a limited cellular net-
work without allowing spread to pathways mediating tonic or
clonic motor activity, providing an entry point to identify the
anatomic substrate for dissociated cortical hypersynchrony.
It is interesting that the loss of one VGLUT3 allele confers inter-
ictal epileptiform abnormalities without evident electrographic
seizures. VGLUT1 and -2 heterozygotes have no obvious behav-
ioral phenotype, but a recent study of the VGLUT1 heterozygote
has suggested abnormalities in anxiety and long-term memory
(Tordera et al., 2007). TheVGLUT2heterozygote showsa specific
defect in nociception (Moechars et al., 2006). Although appar-
ently sufficient to fill vesicles under baseline conditions even
when substantially reduced (Daniels et al., 2006), VGLUT expres-
sionmay thus become limiting under certain conditions, possibly
related to increases in activity. The interictal abnormalities ob-
served in VGLUT3 heterozygous mice may reflect a similar re-
quirement for two wild-type alleles, with one sufficient to prevent
the development of generalized seizures. Considering the ex-treme demands of signaling by IHCs, it is notable that VGLUT3
heterozygotes exhibit no obvious hearing impairment, but future
studymay revealmore subtle abnormalities in sound processing.
The importance of VGLUT3 for neurotransmission at the IHC
synapse known to use glutamate suggests that the transporter
also contributes to glutamate release by neurons usually associ-
ated with a different transmitter. Indeed, VGLUT3 in the cortex
localizes primarily to GABAergic interneurons, as well as to sero-
tonergic projections from the raphe nuclei (Hioki et al., 2004;
Somogyi et al., 2004). Interestingly, dysfunction in a subset of
cortical and hippocampal interneurons due to loss of the DLX1
transcription factor produces seizures resembling those ob-
served in VGLUT3 KO animals (Cobos et al., 2005), suggesting
that the VGLUT3 KO seizure phenotype reflects the loss of gluta-
mate signaling by inhibitory interneurons. VGLUT3 thus has
a physiologically important role in the control of cortical excitabil-
ity, presumably by conferring the release of glutamate from cells
usually associated with GABA. These observations strongly sug-
gest that VGLUT3 also contributes to glutamate signaling by
neurons traditionally considered to release other transmitters.
EXPERIMENTAL PROCEDURES
Generation of VGLUT3 Knockout Mice
A bacterial artificial chromosome (BAC) containing the vglut3 genomic locus
from mouse strain 129S6/SvEvTac was used as a template for PCR to amplify
a 4.5 kb fragment encompassing part of the third intron (right arm) with primers
50-cagagccattcattgattgatgtaag-30 and 50-catcacctgaccctactgagtaataa-30. The
product was subcloned into pPNT (Tybulewicz et al., 1991) at BamHI and KpnI
sites 30 to the neomycin cassette. pPNTwasmodified to include loxP sites sur-
rounding the neomycin cassette. A 2.4 kb fragment (left arm) encompassing
part of the second intron and the first 35 base pairs of the second exonwas am-
plified by PCR using 50-ctgactctgtggtctcaaagtgctag-30 and 50-tggtcccatcgattt
ttcttcatcacc-30 and subcloned at NotI and XhoI sites 50 to the neomycin cas-
sette. The gene encoding the enhanced version of green fluorescent protein
(EGFP) including the stop codon and polyadenylation site was inserted into
the XhoI site of pPNT. The resulting construct was linearized by digestion
withNot1 and transfected into 129/Ola embryonic stemcells (UCSFTransgenic
Core) (Soriano et al., 1991; Thomas and Capecchi, 1987). ES cell clones resis-
tant to both neomycin and gancyclovir were analyzed by Southern blotting of
BamH1-digestedDNAwith the50 probe shown inFigure1A.Out of 300colonies
screened, two had undergone homologous recombination, and each was in-
jected into mouse blastocysts to generate chimeric male mice, which were
then mated to C57Bl/6 females. Chimeras from only one of the clones (11-3;
Figure 1C) showed germ-line transmission of the recombined allele. Heterozy-
gotes from this line weremated to each other and also backcrossed toC57Bl/6
animals. Although the gene coding for EGFP was inserted in-frame with the
N-terminal protein-coding sequence of VGLUT3, EGFP was not observed by
immunofluorescence in VGLUT3KObrain slices. To eliminate possible interfer-
ence by the positive selectable marker, we excised the neomycin cassette by
crossing the F2 VGLUT3 heterozyous mice to mice expressing cre recombi-
nase under the control of the b-actin promoter (which confers expression in
the germline), but still failed to detect EGFP expression. Genotyping was car-
ried out by PCR using a set of primers that only recognizes the wild-type allele
(WT sense: 50-gaaggaaggcccgtgcagac-30 andWT antisense: 50-cttatgtccctaa-
cacatcatg-30) and a set of primers that only recognizes the recombined allele
(KO sense: 50-caatgacgataatgatgatagtaac-30 and KO antisense: 50-gacacgctg
aacttgtggccgtttac-30.
Western Blotting
Crude membrane extracts including synaptic vesicles were prepared from
brains of VGLUT3 KO mice and WT littermates, as described previously (Fon
et al., 1997). Briefly, the brains were homogenized in 1 ml SH buffer (0.32 MNeuron 57, 263–275, January 24, 2008 ª2008 Elsevier Inc. 271
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VGLUT3 in Hearing and Cortical Excitabilitysucrose/10 mM HEPES, pH 7.4) with ten strokes at 900 rpm, sedimented at
1000 3 g for 10 min, and the resulting supernatant at 200,000 3 g for
60 min. Each sample (10 mg) was separated by electrophoresis through 10%
SDS-polyacrylamide, transferred to immobilon, and probed with guinea pig
(GP) anti-VGLUT3 (1:10,000) and mouse anti-synaptophysin (1:3000; Sigma)
followed by incubation with goat anti-GP (1:10,000) or to goat anti-mouse
(1:3000) (Jackson ImmunoResearch) conjugated to horseradish peroxidase
and detection by enhanced chemiluminescence (Amersham Biosciences) us-
ing double emulsion film (Kodak BioMax XAR).
Light and Electron Microscopy
For brain slices, adult micewere anesthetizedwith nembutal and transcardially
perfused with 4% paraformaldehyde (PFA) in phosphate-buffered saline, pH
7.4 (PBS), the brains removed, postfixed in 4% PFA, and transferred to 30%
sucrose. Cryostat sections were incubated as previously described (Fremeau
et al., 2001) with GP anti-VGLUT3 (1:10,000) and either rabbit anti-VAChT
(1:1000), rabbit anti-VGLUT1 (1:1000), or rabbit anti-VGLUT2 (1:1000) at 4C
overnight, followed by incubation with donkey anti-GP antibody conjugated
to Cy3 (1:2000) and donkey anti-rabbit antibody conjugated to FITC
(1:1000). The sections were mounted using Prolong Antifade Gold (Molecular
Probes/Invitrogen) and examined by confocal laser microscopy. Nissl stain
was performed using NeuroTrace 500/525 (InVitrogen).
Sections of cochlea from WT (E15, E19, P1, P2, P5, P21) and VGLUT3 KO
(P21) were prepared as previously described (Akil et al., 2006), preincubated
for 1 hr in PBS containing 0.25% Triton X-100 and 5% normal goat serum (in-
cubation buffer), and then incubated overnight at 4C with primary antibodies:
GP anti-VGLUT1 (1:5000; Chemicon), GP anti-VGLUT2 (1:2500; Chemicon),
rabbit anti-otoferlin (gift from C. Petit), GP anti-VGLUT3 (1:10,000), or rabbit
anti-VGLUT3 (1:500; Synaptic Systems, respectively). Sections were then
washed and incubated for 2 hr with goat anti-rabbit IgG conjugated to FITC
(1:2000), goat anti-GP IgG conjugated to Cy3 (1:2000). The sections were
rinsed in PBS, incubated with DAPI (1.5 mg/ml in PBS; Sigma, St. Louis, MO)
to counterstain nuclei, mounted in glycerol/PBS (1:1 v:v) or in Prolong Antifade
Gold (Invitrogen/Molecular Probes), and examined by confocal microscopy.
Cochlear nucleus volume was measured in P14–15 mice anesthetized with
Isovet and perfused with PBS containing 4% PFA and 1% glutaraldehyde.
After incubation in 30% sucrose, sections were cut at 50 mm,mounted, stained
with thionine, and the boundaries of cochlear subnuclei traced using Neurolu-
cida version 6.0 (Microbrightfield, Inc.) The Cavalieri method was used for 3D
reconstruction and volume calculations. Statistical analysis was performed
using the two-tailed Student’s t test.
Examination of hair cells and histopathology were performed as previously
described (Akil et al., 2006). Spiral ganglion cell counts were performed on
P10 and P21 mice (3 WT and 3 KO at each age). Cochleae were fixed as previ-
ously described (Akil et al., 2006). Serial 5 mm sections were cut parallel to the
modiolus, stainedwith ToluidineBlue, andmountedwith Permount. Eight serial
mid-modiolar sectionswere selected from theapex,mid-turn, andbaseof each
cochlea with approximately the same orientation relative to the mid-modiolus.
In eachsection, theareaofRosenthal’scanalwasdeterminedusingacalibrated
cursor (Image J). Cell counts from each section were based only on cells with
visible nucleoli and were corrected for redundancy using the method of Aber-
crombie (Abercrombie, 1946). Cell densities from the eight sections were aver-
aged, and the reportedcell densities values for eachconditionare themeanand
standard deviation from threemice. Data were collected blind to the genotype,
and statistical analysis was performed using the Student’s t test.
Electron microscopy was performed as previously described (Akil et al.,
2006) except that serial sections through the synaptic region of inner hair cells
were cut in a horizontal plane parallel to the basilar membrane. The morpho-
logical assessment of ribbons and vesicles was done using 15 to 16 different
IHCs from three WT and three KO mice.
RT- PCR of IHC and Cochlea
IHCs from P13–14 rats were dissected away from the rest of the cochlea,
pooled, and both IHCs and whole cochlea used as template for reverse tran-
scriptase (RT)-PCR, as previously described (Akil et al., 2006), using Super-
Script II RNaseH- (Invitrogen) andoligo-dTprimer for 50min at 42C.Reactions
without the reverse transcriptase enzyme (RT) were performed as control,272 Neuron 57, 263–275, January 24, 2008 ª2008 Elsevier Inc.and reactions using the dissection medium as template were used to control
for contamination from lysed cells. The +RT (and RT control) reaction prod-
ucts (2 ml) were then added to individual PCR reactions (GoTaq polymerase;
Promega), each containing a set of intron-spanning primers designed to am-
plify specifically individual VGLUT isoforms, as well as the nAChR a9 subunit.
Primer sequences are as follows: VGLUT1 forward (ctttctacctgctcctcatctc)
and reverse (agtggaggtcctggaaactg), 776 bp; VGLUT2 forward (gcgcaaatctgtt
aggagca) and reverse (ttttctcccagccgttagg), 816 bp; VGLUT3 forward (gctg
gaccttctatttgctctta) and reverse (tctggtaggataatggctcctc), 759 bp; and nAChR
a9 subunit forward (gtgggagtcctcgctgtctgcc) and reverse (gtgagtcccaggtgatg
agccc), 490 bp. All PCR reactions were performed using the following touch-
down protocol (40 cycles total): 94C for 30 s, 60C–50C for 30 s with 1 de-
crease per cycle, 72C for 1 min, followed by 94C for 30 s, 50C for 30 s,
72C for 1min (30 cycles), ending with a 10min extension at 72C, and storage
at 4C. The products were separated by electrophoresis through 2% agarose.
Auditory Testing
Acoustic startle responses of VGLUT3 KO (n = 7) andWT littermate (n = 7) mice
weremeasured in darkened startle chambers (SR-LAB hardware and software,
SanDiego Instruments). Piezoelectric sensors located under the chambers de-
tect andmeasure thepeak startle response.Micewere acclimatized to the star-
tle chambers by presentation of a 70 dBwhite noise for 5min and then exposed
to sound intensities of 80, 90, 100, 105, 110, 120, 125 dB (each with a 0ms rise
time, 40 ms plateau, 0 ms fall time), presented in pseudorandom order with in-
tersound intervals of 10–50 s. Each runwas repeated eight times. Average peak
startle amplitude at each sound level was calculated from eight runs.
Auditory testing including auditory brainstem response (ABR) and distortion
product otoacoustic emissions (DPOAEs) were done as previously described
(Akil et al., 2006), with P21 VGLUT3 KO (n = 5), heterozygotes (n = 5), and WT
littermates (n = 5) and P21 VGLUT1 KO mice (n = 4) (Fremeau et al., 2004a),
heterozygotes (n = 5), andWT littermates (n = 4). For the compound action po-
tential (CAP) recording, a ventral surgical approach (Jero et al., 2001) was used
to expose the right cochlea of P14–17 VGLUT3 KO mice and WT littermates
(n = 5). A fine Teflon-coated silver wire recording electrode was placed in
the round window niche, and the ground electrode was placed in the soft tis-
sue of the neck. The sound stimulus was generated with Tucker-Davis System
II hardware and software (Tucker-Davis).
IHC and Afferent Fiber Recordings
After anesthesia with pentobarbital (0.045 mg/g i.p.), the dissected apical co-
chlear turns of 6- to 16-day-old VGLUT KO, WT littermates, and WT C57Bl/6
mice were placed into the chamber of an upright microscope, the IHCs and
afferent nerve terminals visualized with 403 water-immersion objective and
differential interference contrast optics, and the preparation superfused with
saline at 1–3 ml/min. For isolating IHC Ca2+ currents, the pipette solution con-
tained (in mM) CsMeSO3 135, TEA Cl 13, HEPES-CsOH 5 (pH 7.2), MgCl2 3.5,
Na2ATP 2.5, EGTA 1, and the extracellular solution KCl 5.8, NaCl 115.5, MgCl2
0.9, CaCl2 1.3, D-glucose 5.6, HEPES-NaOH 10 (pH 7.4), TEA Cl 30 as well as
4 mM 4-aminopyridine, 300 nM apamin, and 1 mM tetrodotoxin (Tocris Biosci-
ence). The liquid junction potential (LJP) was 9 mV.
For the analysis of all IHC and afferent conductances other than Ca2+ cur-
rents, the pipette solution contained KCl 135, MgCl2 3.5, CaCl2 0.1, EGTA 5,
HEPES-KOH 5, Na2ATP 2.5; pH 7.2 (KOH) and the extracellular solution KCl
5.8, NaCl 155, CaCl2 1.3, NaH2PO4 0.7, glucose 5.6, HEPES-NaOH 10 (pH
7.4); LJP was 4 mV. Kainic acid, cyclothiazide, and NBQX (Tocris) were
used at concentrations described in the text.
Recording pipettes were fabricated from 1 mm borosilicate glass, and fire
polished with tip resistances of 10–15 (AF) and 4–5 (IHC) MU. Series resistance
errors (5–11 MU) were not compensated for IHC Ca2+ currents and afferent fi-
ber recordings, but were compensated 60%–95% on-line for 26 IHC record-
ings to characterize potassium conductances. For all IHC potassium conduc-
tances, voltages were corrected for the error across the uncompensated
series resistance (<5 MU). Holding potentials were corrected off-line for
LJPs. Recordings were made at 22C–25C with a Multiclamp 700A or 700B
amplifier (Molecular Devices, Sunnyvale, CA) using pClamp version 9.2 or
10.2 and a Digidata 1322A board digitized at 50 kHz and filtered at 10 kHz.
For leak subtraction, IHC membrane resistance was calculated from voltage
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ANOVA with Bonferroni post-tests (Graphpad Prism) were used. The data are
presented as mean ± standard error (SE).
Electroencephalography
Chronic EEG electrodes were implanted in adult (3–7month) VGLUT3 KOmice
and WT littermates. Mice were anesthetized with 0.02 ml/g Avertin (1.25% tri-
bromoethanol/amyl alcohol solution, i.p.). Teflon-coated silver wire electrodes
(0.005 inch diameter) attached to a microminiature connector were implanted
bilaterally into the subdural space over frontal, temporal, parietal, and occipital
cortices. EEG activity was monitored daily during multiple, prolonged over-
night and random 2 hr recording sessions for up to a total of 2 weeks (Stellate
Systems, Harmonie software version 5.0b). A video camera was used to mon-
itor behavior during the EEG recording periods. All recordings were carried out
at least 24 hr after surgery on mice moving freely in the test cage.
Supplemental Data
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/57/2/263/DC1/.
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